Breaking News

U.S. FDA Grants Accelerated Approval for Bayer’s Sevabertinib as First-Line Therapy in Advanced HER2-Mutant NSCLC Following 75% Response Rate

Bayer announced that the U.S. Food and Drug Administration (FDA) has granted accelerated approval for sevabertinib, an oral, targeted HER2 tyrosine kinase inhibitor (TKI), as a first-line treatment for...

MSD Inaugurates New Technology Centre in Hyderabad to Drive Global Healthcare Innovation and Digital Capabilities

MSD (Merck & Co., Inc.), one of the world's leading global life sciences companies, has officially inaugurated its...

Bharat Technology Announces BT-PHARMACON 2K26 with Focus on Indigenous Pharma Innovation

Bharat Technology is set to organise BT-PHARMACON 2K26, an ANRF-sponsored national conference on September 26–27, 2026, at the Eastern Zonal...

ChrysCapital to Acquire 20-25% Stake in Linux Laboratories for ₹600 Crore

Private equity firm ChrysCapital is all set to acquire a strategic stake in Linux Laboratories, a Chennai-based specialty pharmaceutical company focused on central nervous...

India Spotlights Massive Health Workforce Expansion at WHO RC79; SEARO Adopts Historic Dili Declaration

The Ministerial Roundtable addressing on"Human Resources for Health: Equity in Specialized Care" at the 79th Session of the WHO Regional...

Government Introduces Stricter Regulations for Alcohol-Based Oral Medicines

 The Ministry of Health and Family Welfare has formally amended the Drugs Rules, 1945, restricting the free sale of alcohol-based liquid medicines. Notified as...

Glenmark Pharmaceuticals Inc., USA Launches Olanzapine for Injection

Glenmark Pharmaceuticals Inc., USA (Glenmark) has announced the official launch of Olanzapine for Injection, 10mg/vial, available as a Single-Dose Vial.  The newly launched product is bioequivalent...

GSK-partnered Hansoh Pharma reports positive Phase III lung cancer data.

GSK plc shared an announcement from its licensor, HansohPharmaceutical Group Co., Ltd., confirming that the pivotal phase III ARTEMIS-008 trial evaluating risvutatug rezetecan(Ris-Rez) met its primary endpoint...

Health Ministry Completes Nationwide Training Program for Ayushman Arogya Mandir Staff

The Union Health Ministry has completed a two-day National Training of Trainers covering all five categories of primary healthcare staff at Ayushman ArogyaMandirs, hosted at the...

Dr. Reddy’s Issues Immediate Recall of Specific Semaglutide Injection Batches

Dr. Reddy’s Laboratories Ltd. has announced a temporary delay in the commercial supply of semaglutide products marketed in India. The suspension follows a routine assessment revealing that...

Army Hospital R&R Performs First Robotic Stereotactic Brain Stem Biopsy

In a landmark achievement for military medicine, the Neurosurgery Department at the Army Hospital Research & Referral (R&R) has successfully performed the first-ever robotic...